According to Viracta Therapeutics's latest financial reports the company's current earnings (TTM) are -โฌ40.92 M. In 2023 the company made an earning of -โฌ46.08 M a decrease over its 2022 earnings that were of -โฌ44.4 M.The earnings displayed on this page is the company's Pretax Income.